Transient Retinal Effects of 5,6-Dimethylxanthenone-4-acetic Acid (DMXAA, ASA404), an Antitumor Vascular-Disrupting Agent in Phase I Clinical Trials-Reference-Cited by-同舟云学术

Transient Retinal Effects of 5,6-Dimethylxanthenone-4-acetic Acid (DMXAA, ASA404), an Antitumor Vascular-Disrupting Agent in Phase I Clinical Trials

Published:2009-06-01 Issue:6 Volume:50 Page:2553
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Jameson Michael B.¹,Sharp Dianne M.²,Sissingh Jennifer I.²,Hogg Christopher R.³,Thompson Paul I.⁴,McKeage Mark J.⁵,Jeffery Mark⁶,Waller Susan⁷,Acton Gary⁸,Green Colin⁸,Baguley Bruce C.⁹

Affiliation:

1. From the Regional Cancer Centre, Waikato Hospital, Hamilton, New Zealand; the

2. Departments of Ophthalmology and

3. Moorfields Eye Hospital, London, United Kingdom; the

4. Oncology, Auckland City Hospital, Auckland, New Zealand;

5. Department of Pharmacology and Clinical Pharmacology and the

6. Oncology Service, Christchurch Hospital, Christchurch, New Zealand; the

7. Drug Development Office, Cancer Research UK, London, United Kingdom; and

8. Antisoma Research Limited, London, United Kingdom.

9. Auckland Cancer Society Research Centre, University of Auckland, Auckland, New Zealand; the

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel emerging nano-assisted anti-cancer strategies based on the STING pathway;Acta Materia Medica;2023

2. Targeting STING for cancer immunotherapy: From mechanisms to translation;International Immunopharmacology;2022-12

3. The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent—DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors;Cancers;2021-08-04

4. Nitric Oxide in Hematological Cancers: Partner or Rival?;Antioxidants & Redox Signaling;2021-02-10

5. Vascular disrupting agents in cancer therapy;European Journal of Pharmacology;2021-01